| |
Tuberculin skin test
Definition
Tuberculosis (TB) is an airborne infectious disease caused by the
bacteria Mycobacterium tuberculosis. The two most common types of
tests to screen for this disease are the Mantoux PPD tuberculin skin test,
which is generally considered the most reliable, and the TB tine test. These
tests are screening tools that are designed to help identify individuals who
may have been infected by the tuberculosis bacteria. A diagnosis of
tuberculosis is never made based on the results of a TB skin test, but
requires further testing including a
sputum culture and a
chest x ray.
Purpose
Because TB is spread through the air, especially in poorly ventilated
areas, it is more commonly found among people living in crowded conditions,
such as jails, nursing homes, and homeless shelters. Often, a TB skin test
will be given as part of a
physical examination when a person is hiring a new employee,
particularly for those individuals seeking employment in the healthcare or
food service professions.
People can be exposed to TB without showing any symptoms or necessarily
developing the disease. Individuals with normally functioning immune systems
generally prevent the spread of the bacteria by "walling off" or encysting
the bacteria within the body. Anyone who has had close contact with someone
who has active tuberculosis (such as a friend or family member); has been
around someone with active TB; has a weakened immune system (immunocompromised),
either from a chronic disease, such as HIV infection, or as a result of a
tissue or organ transplant or other medical treatment designed to suppress
the immune system; or displays symptoms of the disease should be tested.
Symptoms include a persistent
cough,
fever,
weight loss, night sweats, fatigue, and loss of appetite. Often, individuals
must receive the test in order to enter school or begin work.
Precautions
Although generally considered safe, it is important to inform the person
conducting the test if you may be pregnant, have had a positive TB test in
the past, or have had tuberculosis in the past. People who have had a
positive TB test in the past will probably always have a positive test and
should not be tested again. Also, anyone who is known to have active TB
should not be tested because the local reaction to the test may be so severe
that it requires surgical care.
There are several situations when the TB test results might not be
accurate. These includes situations involving people who:
Description
TB skin tests are usually given at a clinic, hospital, or doctor's
office. Sometimes the tests are given at schools or workplaces. Many cities
provide free TB skin tests and follow-up care. The Mantoux PPD tuberculin
skin test involves injecting a very small amount of a substance called PPD
tuberculin just under the top layer of the skin (intracutaneously).
Tuberculin is a mixture of antigens obtained from the culture of M.
tuberculosis. Antigens are foreign particles or proteins that stimulate
the immune system to produce antibodies. Two different tuberculin
preparations are available, Old Tuberculin (OT) and Purified Protein
Derivative (PPD). The test is usually given on the inside of the forearm
about halfway between the wrist and the elbow, where a small bubble will
form as the tuberculin is injected. The skin test takes just a minute to
administer and feels more like a pinprick than a shot.
After 48-72 hours, the test site will be examined by a trained person for
evidence of swelling. People who have been exposed to tuberculosis will
develop an immune response, causing a slight redness or swelling at the
injection site. Reactions may not peak until after 72 hours in elderly
individuals or those who are being tested for the first time. If there is a
lump or swelling, the health care provider will use a ruler to measure the
size of the reaction.
The other method of TB skin test is called the multiple puncture test or
tine test because the small test instrument has several small tines that
lightly prick the skin. The small points of the instrument are either coated
with dried tuberculin or are used to puncture through a film of liquid
tuberculin. The test is read by measuring the size of the largest papule.
Because it is not possible to precisely control the amount of tuberculin
used in the tine test, a positive test should be verified using the Mantoux
test. For this reason, the tine test is not as widely used as the Mantoux
test and is considered to be less reliable.
Preparation
There is no special preparation needed before a TB skin test. A brief
personal history will be taken to determine whether the person has had
tuberculosis or a TB test before, has been in close contact with anyone with
TB, or has any significant risk factors. Directly before the test, the skin
on the arm at the injection site is usually cleaned with an alcohol swab and
allowed to air dry.
Aftercare
After having a TB skin test, it is extremely important to make sure that
the patient keeps the appointment to have the test reaction read. The
patient is instructed to keep the test site clean, uncovered, and to not
scratch or rub the area. Should severe swelling,
itching, or
pain
occur, or if the patient has trouble breathing, the clinic or health care
provider should be contacted immediately.
Risks
The risk of an adverse reaction is very low. Occasionally, an individual
who has been exposed to the TB bacteria will develop a large reaction in
which the arm swells and is uncomfortable. This reaction should disappear in
two weeks. A sore might develop where the injection was given, or a fever
could occur, but these are extremely rare reactions.
It is possible that a person who has TB may receive a negative test
result (called a "false negative") or a person who does not have TB may
receive a positive test result (called a "false positive"). If there is some
doubt, the test may be repeated or the person may be given a diagnostic test
using a chest x ray and/or sputum sample culture test to determine whether
the disease is present and/or active in the lungs.
Normal
results
In people who have not been exposed to TB, there will be little or no
swelling at the test site after 48-72 hours. This is a negative test.
Negative tests can be interpreted to mean that the person has not been
infected with the tuberculosis bacteria or that the person has been infected
recently and not enough time has elapsed for the body to react to the skin
test. Persons become sensitive between two and ten weeks after the initial
infection. As a result, if the person has been in contact with someone with
tuberculosis, the test should be repeated in three months. Also, because it
may take longer than 72 hours for an elderly individual to develop a
reaction, it may be useful to repeat the TB skin test after one week to
adequately screen these individuals. Immunocompromised persons may be unable
to react sufficiently to the Mantoux test, and either a chest x ray or
sputum sample may be required.
Abnormal
results
A reaction of 5 mm is considered positive for the following groups:
- Household contacts of persons with active tuberculosis
-
AIDS patients
- Persons with old healed tuberculosis.
A reaction of 10 mm is considered positive in individuals with one or
more of the following risk factors:
- Foreign-born from Asia, Africa, or Latin America
- Intravenous drug users
- Medically under-served low income populations
- Residents of long-term care facilities
- Individuals with certain medical conditions that increase the risk of
developing tuberculosis. These medical conditions include being 10% or
more below ideal body weight, chronic renal failure,
diabetes mellitus, high dose corticosteroid or other immunosuppressive
therapy, some blood disorders like leukemia and lymphomas, and other
cancer.
Finally, a reaction of 15 mm is considered positive in those with no risk
factors.
A positive reaction to tuberculin may be the result of a previous natural
infection with M. tuberculosis, infection with a variety of
non-tuberculosis mycobacteria (cross-reaction), or tuberculosis vaccination
with a live, but weakened (attenuated) mycobacterial strain. Cross-reactions
are positive reactions that occur as a result of a person's exposure to
other non-tuberculosis bacteria. These tend to be smaller than those caused
by M. tuberculosis. There is no reliable way of distinguishing
whether a positive TB skin test is due to a previous vaccination against
tuberculosis. Generally, however, positive results are not due to
vaccination exposure because few negative results convert to positive after
vaccination, reactions in vaccinated people tend to be less than 10 mm, and
an individual's sensitivity to tuberculin steadily declines after
vaccination. If the skin test is interpreted as positive, a chest x ray will
be performed to determine whether the person has active tuberculosis or
whether the body has sufficiently handled the infection.
| Terms: |
| Antibody |
| A specific protein produced by
the immune system in response to a specific foreign protein or
particle called an antigen. |
| Antigen |
| Any foreign particle or
protein that causes an immune response. |
| Attenuated |
| A live, but weakened
microorganism that can no longer produce disease. |
| Cross-reaction |
| Positive reactions that occur
as a result of a person's exposure to other non-tuberculosis
bacteria. |
| Immunocompromised |
| A state in which the immune
system is suppressed or not functioning properly. |
| Intracutaneous |
| Into the skin, in this case
directly under the top layer of skin. |
| Mantoux or PPD test |
| Other names for a tuberculin
skin test. PPD stands for purified protein derivative. |
| Percutaneous |
| Onto the skin; without
breaking the skin. |
| Tuberculin |
| A mixture of antigens obtained
from the cultured bacteria that cause tuberculosis, Mycobacterium
tuberculosis. |
|
| Resources: |
| BOOKS |
| Faculty Members at The Yale
University School of Medicine. "Tuberculin Skin Testing." In The
Patient's Guide to Medical Tests, edited by Barry L. Zaret. New
York, NY: Houghton Mifflin Company, 1997. |
| The Merck Manual of Diagnosis
and Therapy. Edited by Robert Berkow. Rahway, NJ: Merck Research
Laboratories, 1992. |
| "Tuberculosis." In Diseases,
edited by Bryan Bunch. Danbury, CT: Scientific Publishing, Inc., 1997. |
| PERIODICALS |
| Advisory Council for the
Elimination of Tuberculosis. "Screening for Tuberculosis and
Tuberculosis Infection in High Risk Populations." Morbidity &
Mortality Weekly Report, 44 (September 8, 1995):19-34. |
| Pouchot, J., et al. "Reliability
of Tuberculin Skin Test Measurement." Annals of Internal Medicine,
126 (February 1, 1997): 210-214. |
| Rose, D.N., et al. "Interpretation
of the Tuberculin Skin Test." Journal of General Internal Medicine,
10 (November 1995): 635-642. |
| Steele, Russell W. "Tuberculosis
in Children: A Growing Concern." Infectious Medicine, 12
(9)(1995): 442, 453. |
| ORGANIZATIONS |
| American Lung Association.
800-LUNG-USA. |
| National Tuberculosis Center.
University of Medicine and Dentistry of New Jersey. Executive Office,
Suite GB1, 65 Bergen Street, Newark, NJ 07107-3268. (800)-4TB-DOCS.
http://www.umdnj.edu/~ntbcweb/ntbchome.htm. |
| |
The above information is an
educational aid only. It is not intended as medical advice for
individual conditions or treatments. Talk to your doctor, nurse or
pharmacist before following any medical regimen to see if it is safe and
effective for you.
|
|
| |
Copyright 1999-2001. The
Thomson Corporation. All rights reserved. MyDiseaseDex(TM) is a
trademark of Micromedex, Inc.
|
|
|
|